OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 197

The journey from melanocytes to melanoma
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 85

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59

Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis
Jie Yu, Ai Zhuang, Xiang Gu, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 52

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 41

Biometallic ions and derivatives: a new direction for cancer immunotherapy
Lin Zhao, Yajun Gui, Jing Cai, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 21
Open Access | Times Cited: 66

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
Soizic Garaud, Marie‐Caroline Dieu‐Nosjean, Karen Willard‐Gallo
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52

Dissolvable Self‐Locking Microneedle Patches Integrated with Immunomodulators for Cancer Immunotherapy
Seung‐Hwan Joo, Jaehyun Kim, Juhyeong Hong, et al.
Advanced Materials (2022) Vol. 35, Iss. 10
Open Access | Times Cited: 46

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Yuanzhuo Gu, Zhengkui Zhang, Peter ten Dijke
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 318-340
Open Access | Times Cited: 31

Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 13

Gut microbiota and its therapeutic implications in tumor microenvironment interactions
Pengya Feng, Xia Xue, Ihtisham Bukhari, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 11

Recent progress of microneedles in transdermal immunotherapy: A review
Xinyi Ai, Jiayi Yang, Zhenda Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124481-124481
Closed Access | Times Cited: 10

Melanogenesis and the Targeted Therapy of Melanoma
Cang Li, Le Kuai, Rutao Cui, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1874-1874
Open Access | Times Cited: 31

Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
Barbara Azzimonti, Chiara Ballacchino, Paola Zanetta, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 546-546
Open Access | Times Cited: 20

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
Yue Liu, Shaojuan Lu, Yihong Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
Emma Cuttini, Camilla Goi, Ester Pellarin, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17

A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
Lulu Sun, Xindan Kang, Houyu Ju, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 17

Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
Xiaojing Qin, Wenjing Ning, Han Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2361-2377
Open Access | Times Cited: 8

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape
X Zhang, Jianbo Shi, Shufang Jin, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 670-694
Open Access | Times Cited: 8

Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma
Marta Di Simone, Anna Maria Corsale, Francesca Toia, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 4, pp. 760-770
Closed Access | Times Cited: 7

Melanocyte lineage dynamics in development, growth and disease
Alessandro Brombin, E. Elizabeth Patton
Development (2024) Vol. 151, Iss. 15
Open Access | Times Cited: 7

Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment
Antonia Reale, Tiffany Khong, Andrew Spencer
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6892-6892
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top